In studies reporting CV benefit associated with weight loss, effects are often attributed to improvements in metabolic abnormalities common in T2D, such as insulin resistance, hyperglycemia, and dyslipidemia [22], as well as reductions in blood pressure, as observed in the Look AHEAD trial [23]
(KPEL News) Insurance companies across the country are dropping coverage for GLP-1 weight-loss medications, and Louisiana residents are losing access to drugs like Wegovy and Zepbound
Targeting these enzymes, either alone or in combination with other immunotherapies, holds promise for improving the outcomes of cancer immunotherapy
A number of circulating factors that control myostatin activity have been discovered
Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort
Nghin cu v nh gi tc ng ca glutathione trong vic ci thin cc vn v da thc hin bi i hc Chulalongkorn, Thailand cho thy: nhn chung, cc ch s hc t melanin v cc vt chy nng trn da u gim nhng ngi tham gia th nghim